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ABSTRACT 
Chronic stress has been associated with obesity, glucose intolerance and insulin resistance. We developed 
a model of chronic psychosocial stress (CPS) in which subordinate mice are vulnerable to obesity and the 
metabolic-like syndrome while dominant mice exhibit a healthy metabolic phenotype. Here we tested the 
hypothesis that the metabolic difference between subordinate and dominant mice is associated with 
changes in functional pathways relevant for insulin sensitivity, glucose and lipid homeostasis. Male mice 
were exposed to CPS for four weeks and fed either a standard diet or a high fat diet (HFD). We first 
measured by real-time-PCR candidate genes in the liver, skeletal muscle and the perigonadal white 
adipose tissue (pWAT). Subsequently, we used a probabilistic analysis approach to analyze different 
ways in which signals can be transmitted across the pathways in each tissue. Results showed that 
subordinate mice displayed a drastic down-regulation of the insulin pathway in liver and muscle, 
indicative of insulin resistance, already on standard diet. Conversely, pWAT showed molecular changes 
suggestive of facilitated fat deposition in an otherwise insulin sensitive tissue. The molecular changes in 
subordinate mice fed standard diet were greater compared to HFD fed controls. Finally, dominant mice 
maintained a substantially normal metabolic and molecular phenotype even when fed a HFD. Overall, our 
data demonstrate that subordination stress is a potent stimulus for the downregulation of the insulin 
signaling pathway in liver and muscle and a major risk factor for the development of obesity, insulin 
resistance and type 2 diabetes mellitus.  
 
INTRODUCTION 
Obesity and Type 2 diabetes mellitus (T2D) are characterized by a multifactorial and polygenic etiology 
(Bouchard 1991, Kahn 1994, Stumvoll 2005). Failure of chronic stress adaptation and socio-economical 
challenges have been related to neuroendocrine and autonomic dysregulations leading to visceral obesity, 
increase in body mass index (BMI) and, development of the metabolic syndrome (MetS) and insulin 
resistance (Van Strien et al. 1986, Rosmond  et al. 1998, Mackenbach JP 1997). Supportive evidence is 
provided for the positive association between hypercortisolemia, increased body weight and T2D (Kyrou 
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et al. 2006, Shpilberg  et al. 2012). Chronic activation of stress response systems (Sapolsky, et al. 2000, 
Koolhaas, et al. 2011) is characterized by visceral fat accumulation and insulin resistance (Kyrou et al. 
2006) associated with high release of glucocorticoids  (Dallman et al. 2006). Moreover, elevated 
glucocorticoid concentrations increase hepatic gluconeogenesis, increase plasma glucose concentration 
and impair the anabolic action of insulin (Dallman et al. 1993, Sapolsky et al. 2000, Dallman 2010). 
However, increased plasma corticosterone concentration, which is consistently a feature of chronic stress 
models, is not always associated with obesity vulnerability. Indeed, several models of stress are 
associated with hypophagia or unaltered food intake and weight loss (Dallman et al. 2006, Harris 2015, 
Razzoli et al., 2016). Despite several genetic or pharmacological animal models of MetS and T2D having 
been developed, so far there is a paucity of models linking socio-economic status, stress, MetS and T2D 
that are suitable to investigate the underlying molecular mechanisms. Social subordination stress has long 
been considered ideal to mimic the impact of psychosocial stress on human pathologies (Bartolomucci et 
al. 2005, Sapolsky 2005, Koolhaas et al. 2011, Scott et al. 2012). We previously validated a mouse model 
of chronic psychosocial stress (CPS) -induced derangements toward obesity and MetS (Bartolomucci et 
al. 2005, Bartolomucci et al. 2009, Dadomo et al. 2011, Sanghez et al. 2013). Based on these results, we 
hypothesized that this phenotype may provide key information about early pathogenically relevant 
metabolic disturbances induced by psychosocial stress without the confounding secondary effects derived 
from severe metabolic disturbance in morbidly obese animals. Specifically, we tested the hypothesis that 
the metabolic difference between subordinate and dominant mice was associated with changes in 
functional pathways relevant for insulin sensitivity, glucose and lipid homeostasis. Accordingly, we 
combined the analysis of candidate metabolic genes regulating insulin signaling, glucose and lipid 
homeostasis by real-time quantitative PCR in liver, skeletal muscle (quadriceps) and perigonadal white 
adipose tissue (pWAT); pWAT was selected because it is one of the largest and better characterized 
visceral fat pads in mice (de Jong et al., 2015) of subordinate and dominant mice fed a standard diet, and 
for comparison in control mice fed a high fat diet (HFD). Further we analyzed by qPCR the same genes in 
mice undergoing stress and fed a HFD. Finally, we used a novel bioinformatics analysis of selected 
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functional signaling pathways (insulin, peroxisome proliferator-activated receptor (PPAR) and 
adipokines).   
 
METHODS 
Animals  
Male CD1 mice derived from an outbred stock were obtained from Charles River Italy. Mice were reared 
in groups of 4-6 same sex siblings in a 12:12 hour light:dark cycle (lights on at 07:00h) at 22 ± 2 °C (see 
Razzoli et al., 2016, for a discussion on the relevance of the environmental temperature on the stress-
induced metabolic phenotype). Animal experiments were conducted at the University of Parma (Italy) and 
approved by the ethical committee of the University of Parma. 
Diets: Mice were fed standard diet (4RF21, Mucedola 3.9Kcal/g, 6.5% Kcal from fat) or HFD (Mucedola 
modified 4RF21, 5.2Kcal/g and 45%Kcal from fat).  
 
Chronic psychosocial stress protocol 
We used our standard protocol (Bartolomucci et al. 2004, Bartolomucci et al. 2005, Bartolomucci et al. 
2009, Dadomo et al. 2011, Sanghez et al. 2013) in which stable resident/intruder pairs of adult male mice 
were formed after a baseline period lasting 5 days in which mice were isolated to establish territorial 
ownership and to collect basal metabolic parameters. At the beginning of the phase of stress for four 
weeks each resident received an unfamiliar weight-matched intruder mouse and the two mice were 
allowed to freely interact for 10 min. After the interaction, residents and intruders were separated by a 
perforated partition, which allowed continuous visual, auditory and olfactory sensory contact but no 
physical interaction. The partition was removed daily (between 08:00h and 09:00h), for a maximum of 10 
min. During social interaction offensive behavior was manually recorded and social status of the mice 
was determined. Only dyads that reliably showed a stable dominant/subordinate hierarchy and in which 
the subordinate showed no attack after day 4 were included in the study. Age and weight-matched mice, 
housed in groups of 3 siblings, were included as a control group according to our standard validated 
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protocol (Bartolomucci et al. 2004; additional details are in Bartolomucci et al. 2004 and Sanghez et al. 
2013). The metabolic phenotype of CPS-exposed mice has been described in detail (Sanghez et al. 2013); 
previously published physiological results are presented in Supplementary Table1 for reference. The 
present study investigated the molecular changes in tissues collected from the same mice described in our 
previous paper (Sanghez et al. 2013). Mice were euthanized by decapitation following brief CO2 exposure 
between 09:00h and 11:00h within 3 min after an experimenter entered the animal room. Liver, 
quadriceps (hereafter referred to as skeletal muscle) and perigonadal white adipose tissue (pWAT) were 
collected under aseptic conditions and stored in RNase-free tubes at -80C. 
 
Real Time PCR 
Total RNA was isolated from pWAT, liver and skeletal muscle using STAT60 isolation reagent (Tel-Test, 
Inc., USA). RNA integrity was assessed with electrophoresis agarose gel by Sybr-safe stain (Invitrogen). 
Real-time quantitative PCR was performed to quantify the expression of candidate genes involved in 
insulin signaling, glucose and lipid metabolism (a full list of genes measured including values for genes 
showing no significant changes in expression are in Table S2), using TaqMan or a SybrGreen sequence 
detection system on an ABI 7900 instrument (Applied Biosystem) as described by (Pfaffl et al. 2004). 
Expression of each target gene was corrected by the geometrical average of 4 different housekeeping 
genes: 18S, β2-microglobulin, β-actin and 36B4 using the best-keeper tool (Pfaffl et al. 2004).  
 
Statistical analysis. 
Data were analyzed with unpaired t-tests, two-way ANOVA and two-way repeated measures ANOVA 
followed by Tukey’s HSD or Duncan post hoc tests by using Statistica (Statsoft, Inc. Tulsa, OK). P values 
less than 0.05 were considered statistically significant. Significance level is indicated in the figure 
legends. Data are presented as mean + SEM.  
 
Pathway analysis  
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We used here a probabilistic approach to analyze the possible different functionalities resulting from the 
different ways in which signals can be transmitted across a pathway. Gene activity, estimated from the 
level of expression, can be used within a probabilistic context to calculate the probabilities of a signal to 
be transmitted from the input node (receptor proteins) to the output node (effector proteins) in a pathway. 
Differential activity in distinct input/output connections will result in different functional activities 
triggered by the pathway. Here we used a new approach in which, instead of analyzing the activity of the 
pathway as a whole, we rather analyze the possible different functionalities resulting from the different 
ways in which signals can be transmitted across the pathway. These different stimulus-response pathways 
we call sub-pathways.  
The method we used performs four steps. 1. The first step is the modeling of signaling pathways extracted 
from KEGG (Kyoto Encyclopedia of Genes and Genomes). This is done once for each studied pathway 
by taking into account the relationships of activation or repression established between gene products. 2. 
The second step consists of computing the activity of each gene product (calculated from the PCR 
expression experiment described above) in the modeled pathways. The normalized gene expression data 
are rescaled from the range of variation to a 0-1 interval range. As a result, the higher values represent the 
most expressed (or activated) data. Furthermore, a KEGG pathway node can contain one or more gene 
products. The node information is summarized using the 95% percentile of the corresponding normalized 
gene expression values. The method proposed to model the pathways can easily deal with missing data. 
The final score for relevant sub-pathways for which critical nodes are measured are calculated as 
weighted products of the normalized expression values. Therefore, a missing measurement can be 
substituted by a 1 in all the compared conditions (Hernansaiz-Ballesteros et al., 2015). Consequently, the 
contribution of this particular gene to the final score is null and only the contributions of the genes 
measured are taken into account.  3. The third step is to calculate the probability of activation of each sub-
pathway from a pathway, based upon the following concepts: i) Input node is any receptor node which 
does not receive signal from any other node in the pathway and starts the signaling process according to 
the KEGG diagram, unless this node is an inhibitor; ii) Output node is any effector node at the end of the 
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transmission of the signal; iii) Sub-pathway is a sequence of nodes between an input and a connected 
output node. The probabilities of each node along the sub-pathway is propagated using the 'Inclusion–
exclusion principle'.. The propagated product of probabilities takes only into account the effect of the 
available gene measurements. Genes with no measurements available are set to 1 and, consequently, do 
not affect to the resulting product. 4. Finally, after the second and third steps have been performed on 
each sub-pathway from a pathway and also on each sample of the experiment, a Wilcoxon test is applied 
in order to assess the significance of the differential activations of each sub-pathway, which will account 
only for the effect attributable to the measured genes. Thus, the limitation of not having measurements for 
all the genes in the pathway is partly overcome by the pathway analysis strategy used. The methodology 
for sub-pathway analysis is explained in detail elsewhere (Sebastián-León et al. 2013, Sebastian-Leon et 
al. 2014). The current analysis only includes pathways in which more than six genes were directly 
measured. Other pathways and sub-pathways were excluded.  Figures were generated using the CellMaps 
tool (http://cellmaps.babelomics.org/) in the Babelomics platform (Alonso et al., 2015). 
 
RESULTS 
Opposite stress-induced metabolic consequences in dominant and subordinate mice  
We previously reported the opposite metabolic phenotypes developed by subordinate and dominant mice 
exposed to CPS (Bartolomucci et al. 2009, Sanghez et al. 2013). Specifically, despite showing similar 
food intakes and plasma corticosterone concentrations, subordinate and dominant mice exhibited opposite 
changes in body weight and adiposity (Table S1 summarizes findings described previously (Sanghez et al. 
2013). Overall, subordinate mice showed a significant gain in body weight and pWAT mass, an 
obesogenic effect exacerbated by HFD when compared with control mice. On the contrary, dominant 
mice were resistant to diet-induced obesity. HFD and subordination stress were associated with increased 
circulating fasting total cholesterol, HDL and non-esterified fatty acid (NEFA) concentrations. The 
combination of chronic subordination stress and HFD exacerbated these metabolic abnormalities (Table 
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S1). After 4 weeks of stress no significant changes in basal plasma glucose concentration or glucose 
tolerance were detected in mice fed standard diet. However, when subordinate mice were fed a HFD, they 
showed fasting hyperglycemia and glucose intolerance in the glucose tolerance test (GTT) as well as high 
homeostatic model assessment of insulin resistance (HOMA-IR) and low quantitative insulin sensitivity 
check index (QUICKI) when compared to all the other experimental groups (Table S1).  
 
High fat diet-induced molecular changes in control mice  
As expected, the molecular analysis conducted in control mice fed HFD for 3 weeks showed, compared to 
control mice fed standard diet, that mRNA expression of candidate genes associated with insulin 
resistance and diabetes, such as insulin receptor substrate 1 and 2 (IRS1, IRS2), were down-regulated in 
liver (IRS1, t37=2.5, p<0.01; IRS2, t37=4.2, p<0.001), while in skeletal muscle IRS2 was down-regulated 
(t37=3.1, p<0.01) .  Moreover, the gene for carnitine palmitoyltransferase (CPT1α) was down-regulated 
(t37=6.5, p<0.0001), while the genes for insulin independent glucose transporter GLUT2 (t36=6.4, 
p<0.0001) and insulin receptor (IR) (t37=3.0, p<0.01) were up-regulated in liver and skeletal muscle 
respectively (Figure 1A). In pWAT there was an increase in adipocyte protein 2 (aP2, t36=2.2, p<0.05) 
and leptin (t35=3.8, p<0.001) gene expression, while PPARs genes were not affected by HFD (Figure 1A).  
 
Opposite effect of social status on the molecular signature of MetS and insulin resistance in mice 
fed standard diet 
Our molecular analysis revealed that subordinate mice fed standard diet, despite remaining euglycemic, 
exhibited molecular signatures of insulin resistance in liver and muscle, but not in pWAT (Table S1).  
Analysis of the candidate genes with quantitative PCR showed in subordinate mice decreased IRS2, and 
CPT1α, but not of IRS1, gene expression in liver (Figure 2;, IRS2, F(2,52)=11.6, p<0.0001, 
CPT1F(2,52)=6.24, p<0.01), and of IRS2 gene expression in skeletal muscle (Figure 3; F(2,49)=7.1, 
p<0.01), while expression of GLUT2 and IR genes were up-regulated in liver (Figure 3; GLUT2, 
F(2,52)=6.3, p<0.01, IR, F(2,52)=3.9, p<0.05). The pWAT (Figure 4) of subordinate mice showed an 
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anabolic pattern of lipid metabolism gene expression characterized by increased expression of genes for  
lipoprotein lipase (LPL, F(2,52)=7.44, p<0.01), adipocyte protein 2 (aP2, F(2,53)=7.5, p<0.001), PPARγ2 
(F(2,53)=3.7, p<0.05) as wells as for adiponectin (F(2,52)=10.8, p<0.001), when compared with control 
mice (Figure 4).  
 
 
Subordination but not dominance stress exacerbated molecular signatures of MetS and insulin 
resistance in presence of high fat diet 
Subordinate mice fed a HFD manifested glucose intolerance and insulin resistance (Sanghez et al. 2013) 
(Table S1). Based on the results obtained in mice fed standard diet we hypothesized that social 
subordination would further exacerbate the metabolic pattern of insulin resistance in the context of HFD 
feeding. At the single gene level we observed in subordinate mice fed HFD, when compared to all other 
groups, a further significant decrease in expression in liver of genes for IRS2 (F(3,68)=11.3, p<0.0001) 
and CpT1α (F(3,68)=27.9, p<0.0001) (Figure 2B), and decreased expression in skeletal muscle of genes 
for IRS2 (F(3,68)=10.5, p<0.0001) and PPARγ1 (F(3,65)=3.5, p<0.05) (Figure 3B), and decreased 
expression in pWAT of genes for PPARγ1 (Figure 4B; F(3,66)=8.4, p<0.0001),. Subordinate mice fed 
HFD also showed a down-regulation in liver of expression of PEPCK and pyruvate carboxylase (PC) 
mRNAs (Figure 2B; F(3,68)=3.9, p<0.05,  F(3,68)= 3.38, p<0.05) respectively), whereby excluding a 
significant role of gluconeogenesis on reported fasting hyperglycemia (Sanghez et al., 2013). In 
agreement with the relatively conserved homeostasis in dominant mice fed HFD, this group only showed 
minor molecular changes (Figure 2, Figure 3, Figure 4). 
 
Pathway analysis reveals minor global metabolic changes in control mice fed a high fat diet  
The pathway analysis conducted in the pWAT of control mice fed HFD revealed an up-regulation of 
glucose uptake, growth and proliferation sub-pathways downstream of leptin in the adipokines pathway, 
and a down-regulation in the nodes involved in antilipolysis in the insulin pathway compared to control 
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mice fed standard diet (Figure S1). Overall, the insulin and PPAR pathways in muscle and liver remained 
substantially unaffected after three weeks of HFD (Figure S1). Finally, protein synthesis, proliferation and 
differentiation sub-pathways in the Insulin pathways were up-regulated in skeletal muscle (Figure S1). 
Overall, short term HFD was sufficient to induce mild transcriptional alterations in insulin resistance 
biomarkers in metabolic tissues.  
 
Opposite effect of social status on the molecular signature of MetS and Insulin resistance in mice 
fed standard diet 
We next performed the pathway analysis on the liver, skeletal muscle and pWAT of subordinate and 
dominant mice fed a standard diet or a HFD compared to respective control groups. The liver and skeletal 
muscle of subordinate mice fed a standard diet manifested a significant down-regulation of all sub-
pathways in the insulin pathway (Figure 5) and lipid metabolism in the PPAR signaling pathways (Figure  
6). Conversely, in the pWAT we observed an up-regulation of the nodes immediately downstream of anti-
lipolysis in the insulin pathway (Figure 5) as well as an up-regulation of the leptin sub-pathway with all 
the nodes involved in glucose uptake and FFA metabolism  (Figure..7). Moreover, the adiponectin 
pathway downstream of adiponectin was up-regulated in pWAT (Figure 7). Overall, we conclude that at 
this early stage of development of metabolic disorder, subordinate mice manifest molecular signatures of 
insulin resistance in liver and muscle while the adipose tissue remained insulin sensitive, though showing 
an increase in pathways facilitating fat accrual. Remarkably, the worsening of insulin resistance 
associated with being a subordinate is larger in magnitude compared to the effects of HFD in control mice 
(Figure S1). 
In agreement with the healthy metabolic phenotype (Table S1), the gene expression and pathway analysis 
showed a substantially normal profile in metabolic tissue from dominant mice fed a standard diet. 
Notably, dominant mice showed up-regulated sub-pathways for glycolysis and lipogenesis in the insulin 
pathway and down-regulated leptin and adiponectin sub-pathways in the main adipokines pathway in 
11 
 
pWAT (Figure 5); in addition the gluconeogenesis sub-pathway in the PPARs pathway in the liver was 
up-regulated (Figure 6).  
Finally we performed a pathway analysis in tissue from subordinate and dominant mice fed a HFD and 
compared to control mice fed HFD. Overall, the pathway analysis in both subordinate and dominant mice  
revealed only minor changes compared to the effects shown when fed standard diet, indicating that the 
global gene programming is more sensitive to subordination stress than to HFD per se (Figure S2). 
 
DISCUSSION 
Obesity is a major risk factor for insulin resistance and T2D (Surwit et al. 1988, Winzell et al. 2004, 
Buettner et al. 2006, Karasawa et al. 2009). Similarly, psychosocial stress-induced metabolic disorders 
have been established in humans (Dallman et al. 2006, Bose et al. 2009), primates (Shively et al. 2009) 
and rodents (Bartolomucci et al. 2004, Kuo et al. 2007, Bartolomucci et al. 2009, Coccurello et al. 2009, 
Finger et al. 2011). We developed a naturalistic model of chronic psychosocial stress (CPS) in which low 
social rank mice (subordinate) are vulnerable to obesity and the metabolic-like syndrome while high 
social rank mice (dominant) exhibit a healthy metabolic phenotype (Bartolomucci et al., 2009, Sanghez et 
al., 2013).  In the present study we tested the hypothesis that the opposite metabolic phenotype of 
subordinate and dominant mice is associated with changes in functional pathways relevant for insulin 
sensitivity, and glucose and lipid homeostasis. Our results demonstrate that subordinate mice manifest a 
molecular signature of insulin resistance in skeletal muscle and liver which is larger in magnitude than the 
effect of HFD per se in control mice and can be observed before hyperglycemia develops (Figure 8). 
Importantly, subordination stress interacted with HFD to exacerbate glucose intolerance and insulin 
resistance (Sanghez et al. 2013) as well as molecular changes in metabolically relevant organs. On the 
contrary, dominant mice showed an overall healthy metabolic phenotype (Sanghez et al., 2013) and 
largely normal expression of genes implicated in insulin sensitivity and glucose and lipid homeostasis.  
In this study we combined the quantitative PCR expression analysis of candidate genes and 
bioinformatics models based on the well-known descriptions of signaling pathways taken from the KEGG 
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repository. KEGG devotes a complete section to cell signaling (Environmental Information Processing) 
that includes more than 40 pathways of signal transduction as well as signaling molecules and 
interactions. Within these pathways, the different sub-pathways leading from a specific stimulus received 
by a receptor protein to a particular response triggered by an effector protein have been defined 
(Sebastian-Leon et al, 2013, 2014). While the pathway models have been demonstrated to be quite 
accurate in terms of having a much reduced rate of false positive and false negative results, pathway 
models do have several weaknesses as well. One limitation is the fact that gene expression measurements 
are taken as proxies for protein production and subsequent activation. To limit this potential confounding 
factor we considered here the coordinated activation/deactivation of groups of genes within the context of 
a signaling sub-pathway. Furthermore, we have demonstrated that available phosphoproteomic 
measurements agree with the sub-pathway activity predictions made on the basis of the corresponding 
gene expression values (Amadoz et al., 2016). A second limitation of the method is that it can only be 
applied to known pathways. If, for some reason, the pathway underwent some modification, the model 
will ignore it and predictions will not be (to full extent) representative of the real signaling. This criticism, 
however, is extendable to any method based on pre-defined pathways and additionally, in order to 
minimize this risk we selected genes with a rather well-established functional role.  
 
Severe down-regulation of insulin signaling in liver and muscle in subordinate mice 
Our previous work established that chronic subordination stress is associated with hyperphagia and 
dyslipidemia but normal glucose tolerance in mice fed standard diet (Sanghez et al. 2013). Conversely the 
development of glucose intolerance and insulin resistance required the additive effect of high fat diet and 
subordination stress (Bartolomucci et al. 2009, Dadomo et al. 2011, Sanghez et al. 2013). Here we 
showed that subordinate mice fed a standard diet are already characterized by a marked down-regulation 
of key genes implicated in glucose homeostasis as well as a global down-regulation of the insulin 
signaling pathway in liver and muscle, but not the perigonadal adipose tissue, which is in agreement with 
the preferential deposition of fat in WAT (Figure 5). Among the metabolic and endocrine changes 
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observed in subordinate mice, glucocorticoids and FFA can be considered the major factors contributing 
to the down-regulation of the insulin signaling pathway (Kahn 1994, Stumvoll 2005, Taniguchi et al. 
2006, Shpilberg et al. 2012, Sanghez et al. 2013). In particular, excessive FFA leading to lipotoxicity is a 
recognized risk factor for the development of insulin resistance (Virtue et al. 2010) and has been 
mechanistically linked to a down-regulation of the IRS and PPARs signaling pathway in metabolic tissues 
(Forman et al. 1996, Lewis et al. 2002). Interestingly, CPT1α, which is essential for fatty acid oxidation 
(Sebastián et al. 2009), was down-regulated in muscle and liver of subordinate mice. CPT1α inhibition 
reduces long chain fatty acid (LCFA) transport into and oxidation in muscle mitochondria resulting in an 
increase in FFA levels (McGarry 2002), thus potentially contributing to the dyslipidemia observed in our 
model (Sanghez et al. 2013). Decreased IRS2 appears to be the key molecular node critically down-
regulated in the signaling pathway of subordinate mice (Taniguchi et al. 2006) (Figure 2 and Figure 3). 
Germline or conditional ablation of IRS2 as well as viral delivery of antisense oligonucleotides for IRS2 
leads to T2D in mice (Withers et al. 1998, Taniguchi et al. 2006). Conversely, pharmacologically-induced 
up-regulation of IRS2 leads to improved glucose tolerance (Cao et al. 2011). Altogether, the changes in 
gene expression were observed in the context of euglycemia and increased GLUT2 and IR in the liver, 
thus suggestive of the development of compensatory mechanisms able to normalize circulating glucose 
(Guillam et al. 1997, Thorens et al. 2000). 
Molecular changes observed in subordinate mice fed standard diet (as well as those fed HFD) were larger 
in magnitude compared to the effects exerted by a comparable HFD treatment in control mice. This 
suggests that down-regulation of the insulin signaling pathway should be regarded as an early molecular 
biomarker of T2D (Sanghez et al. 2013). Several lines of evidence support this conclusion. Firstly, human 
studies of T2D showed that insulin sensitivity and glucose disposal are defective in still normoglycaemic 
patients more than a decade before diagnosis of disease. Secondly, reduced insulin signaling has been 
reported for insulin-resistant and diabetic patients as well as in most of the animal models of T2D 
(Olefsky et al. 1982). Thirdly, in contrast to IRS1/2 deficient strains, mice heterozygous for IRS1 showed 
hyperinsulinemia and glucose intolerance only in the presence of obesity (Shirakami, Toyonaga et al. 
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2002). Finally, mice heterozygous for double IR and IRS1 gene deficiency (with a ~50-70% reduction in 
the level of protein expression and function), develop a slow onset T2D (Brüning et al. 1997). 
Interestingly, only a subgroup of double heterozygous mice developed T2D and the causal factor remains 
unexplained. In this scenario, our data suggest that chronic stress might be a relevant environmental factor 
explaining individual vulnerability to develop T2D. Specifically, our model supports the multi-stage and 
polygenic model for T2D and suggests that the disease develops in the presence of concomitant 
environmental/genetic risk factors. In support, we recently showed that subordination stress aggravates 
glucose intolerance in leptin receptor mutant db/db mice (Razzoli et al. 2015).  
 
Dominant mice are characterized by a substantially normal expression of molecular markers of 
insulin resistance in metabolic tissues 
We previously established that dominant mice in the chronic psychosocial stress model manifest a healthy 
metabolic phenotype characterized by normal body weight, lipid profile and glucose tolerance despite the 
mice being hyperphagic and showing sustained stress-induced hyperactivation of the hypothalamo-
pituitary-adrenal (HPA) axis (Sanghez et al. 2013). In support, using a combined candidate gene and 
pathway analysis we demonstrated here that dominant mice have a substantially normal expression of 
molecular markers of insulin resistance in metabolic tissues. The more prominent phenotypes of dominant 
mice are sustained increase in body temperature, increased energy expenditure, hyperactivity and 
increased sympathetic tone to adipose tissue, resulting in smaller adipocyte diameter (Bartolomucci et al. 
2004, Moles et al. 2006, Bartolomucci et al. 2009). Additionally, preventing stress-induced hyperphagia 
with a pair-feeding protocol normalizes weight gain and obesity, and  improves glucose intolerance in 
subordinate mice (Razzoli et al. 2015) while dominant mice showed a substantial weight and fat mass loss 
(Sanghez et al., unpublished). Overall, the more likely explanation for the healthy metabolic phenotype 
shown by dominant mice is that the high energetic cost in establishing and maintaining dominance 
(Sapolsky 2005, Moles et al. 2006) prevents the development of dyslipidemia and lipotoxicity observed in 
subordinate mice, thus limiting the development of glucose intolerance even in the presence of 
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hyperphagia and high fat diet feeding. Sympathetic hyperactivity can be associated with severe disease 
such as heart failure and atherosclerosis (Fisher et al. 2009). Accordingly, it remains to be investigated 
whether dominant mice develop other stress-associated diseases despite being apparently metabolically 
healthy. This conclusion is supported by accumulating evidence for a physiological ‘cost of being 
dominant’ in naturalistic and semi-naturalistic settings (Bartolomucci et al. 2005, Sapolsky 2005, 
Gesquiere et al. 2011); an ongoing study is testing the effect of social status on senescence and mortality 
in mice (Razzoli, Bartolomucci, unpublished). A limitation of the present study is that the metabolic and 
molecular analysis was conducted in healthy wild type mice only. The observed metabolic effects suggest 
that genetic/disease mouse models showing impaired insulin signaling should be more vulnerable to 
stress-induced T2D, while mice carrying a transgenic over-expression of IRS1/2 in liver and or muscle 
should be protected from the metabolic derangement of subordination stress. Further studies are required 
to test this mechanistic hypothesis.  
 
CONCLUSIONS 
In summary, we have demonstrated that three weeks of chronic psychosocial stress (in mice housed at 
room temperature (Razzoli et al., 2016)) resulted in a molecular signature of insulin resistance in liver and 
muscle but not in the pWAT of subordinate mice. Remarkably, molecular signatures of insulin resistance 
in subordinate mice fed a standard diet were larger in magnitude compared to changes in control mice on 
a HFD. However, dominance status conferred a protection against stress-induced molecular derangements 
that lead to T2D diabetes. 
It is appropriate to point out that non-genetic mouse models developed so far have largely failed to 
recapitulate the complex metabolic disorder observed under conditions of chronic stress characterized by 
insulin resistance observed in the human clinical population (Harris 2015). Here we established a model 
of physiological and molecular signature of insulin resistance in an outbred mouse strain characterized by 
high genetic heterogeneity (Aldinger et al. 2009), thus extending the generalizability of the results 
obtained to a general human population.  
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FIGURE LEGENDS 
Figure 1. Molecular effect of HFD feeding in control mice.  Real time PCR analysis of candidate genes 
measured in the liver, muscle and perigonadal white adipose tissue (pWAT) of control mice fed a 
standard (STD) or a high fat diet (HFD). Data were analyzed using unpaired t-test, #p<0.07 (tendency 
only), *p<0.05,**p<0.01, ***p<0.001. Number of mice per group (n): STD CON n=16-19,  HFD CON 
n=20-23. Data are mean +/- SEM. 
 
Figure 2. qPCR analysis of candidate genes in the liver of subordinate (SUB) and dominant (DOM) mice 
fed (A) standard diet (STD) and (B) high fat diet (HFD) compare to Controls (CON). Data were analyzed 
using two-way ANOVA followed by Tukey’s HSD post hoc test, #p<0.07, *p<0.05,**p<0.01, 
***p<0.001. Asterisk (*)represent significant differences, hash sign (#) alone indicates tendency, vs CON 
mice; bars identify significant differences between indicated treatments. Number of mice per group (n): 
STD CON n=16-19, STD SUB n= 20-22, STD DOM n= 15-23, HFD CON n=20-23, HFD SUB n= 22-
26, HFD DOM n=7-8. Data are mean +/- SEM. 
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Figure 3. qPCR analysis of candidate genes in the skeletal muscle of subordinate (SUB) and dominant 
(DOM) mice fed (A) standard diet (STD) and (B) high fat diet (HFD) compare to Controls (CON). Data 
were analyzed using two-way ANOVA followed by Tukey’s HSD post hoc test. #p<0.07, 
*p<0.05,**p<0.01, ***p<0.001. Asterisks (*)represent significant, differences, hash sign (#) alone 
indicates tendency, vs CON mice; bars identify significant differences between indicated treatments. 
Number of mice per group (n): STD CON n=16-19, STD SUB n= 20-22, STD DOM n= 15-23, HFD 
CON n=20-23, HFD SUB n= 22-26, HFD DOM n=7-8. Data are mean +/- SEM. 
 
Figure 4. qPCR analysis of candidate genes in the perigonadal white adipose tissue (pWAT) of 
subordinate (SUB) and dominant (DOM) mice fed (A) standard diet (STD) and (B) high fat diet (HFD) 
compare to Controls (CON). Data were analyzed using two-way ANOVA followed by Tukey’s HSD post 
hoc test. #p<0.07, *p<0.05,**p<0.01, ***p<0.001. Asterisks (*)represent significant differences, hash 
sign (#) alone indicates tendency, vs CON mice; bars identify significant differences between indicated 
treatments. Number of mice per group (n): STD CON n=16-19, STD SUB n= 20-22, STD DOM n= 15-
23, HFD CON n=20-23, HFD SUB n= 22-26, HFD DOM n=7-8. Data are mean +/- SEM. 
 
Figure 5. Insulin signaling pathway analysis in subordinate (SUB) and dominant (DOM) mice fed a 
standard diet (SD) compared to controls (CON). Based on PCR data from tissues shown in Figures 2-4. 
Representation of insulin pathway in liver, skeletal muscle and perigonadal white adipose tissue (pWAT). 
Sub-pathways significantly up-regulated in the condition of interest (SUB or DOM) compared to CON 
are represented with all this group of nodes in red. Sub-pathways significantly down-regulated are 
represented with all the nodes in blue.  SUB mice showed a down-regulation in all the sub-pathways in 
the insulin pathway for both liver and muscle. In contrast DOM showed only an up-regulation of 
glycolysis in skeletal muscle, and glycolysis and lipogenesis in liver. Both SUB and DOM mice showed 
an upregulated antilipolysis subpathway in pWATFurther details on the representation of the pathway 
analysis are in Figure S4. 
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Figure 6. PPARs signaling pathway analysis in subordinate (SUB) and dominant (DOM) mice fed a 
standard diet (SD) compared to controls (CON). Representation of PPARs pathway in liver and skeletal 
muscle. Based on PCR data from tissues shown in Figures 2-4. Sub-pathways significantly up-regulated 
in the condition of interest (SUB or DOM at STD) compared to CON-STD are represented with all the 
nodes in red.. Sub-pathways significantly down-regulated are represented with all the nodes in blue.  SUB 
mice showed a down-regulation in the lipid metabolism sub-pathway in liver and skeletal muscle when 
compare to CON fed STD. DOM exhibited a down-regulation of lipid metabolism in skeletal muscle 
while in liver the lipid metabolism node is represented with a purple color identifying a node belonging to 
more than one significant sub-pathway having different behaviors (CD36-up-regulated and Sc1-down-
regulated). DOM also showed an up-regulation of gluconeogenesis in the liver. Further details on the 
representation of the pathway analysis appear in the Figure 1 legend. Further details on the representation 
of the pathway analysis appear in Figure S5. 
 
Figure 7. Adipokine signaling pathway analysis in the perigonadal white adipose tissue (pWAT) in 
subordinate (SUB) and dominant (DOM) mice fed a standard diet (SD) compared to controls (CON). 
Based on PCR data from tissues shown in Figures 2-4.   Sub-pathways significantly up-regulated in the 
condition of interest (SUB or DOM) compared to CON are represented with all this group of nodes in red. 
Sub-pathways significantly down-regulated are represented with all the nodes in blue.  SUB showed an 
up-regulation in glucose uptake an adiponectin sub-pathways while DOM showed a down-regulation 
compared to CON. Further details on the representation of the pathway analysis appear in Figure S3. 
 
 
Figure 8. Summary of the main findings of the study. The relative size of arrows is proportional to the 
number of sub-pathways being significantly up- or down- regulated within each pathway compared to 
controls. Color coding is congruent with the pathway analysis, i.e. red for up-regulated and blue for 
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down-regulated pathways. When a candidate gene was associated and suggested to play a main role in the 
signaling pathway its name is noted in parenthesis. STD: standard diet; HFD: high fat diet; pWAT: 
perigonadal white adipose tissue. 
 
 

AB
AB
AB
SUBORDINATE DOMINANT
Li
ve
r
Sk
el
et
al
 m
us
cl
e
pW
A
T
L
iv
er
SUBORDINATE DOMINANT
S
ke
le
ta
l M
us
cl
e
DOMINANTSUBORDINATE
pW
A
T

Supplementary Table 1: Analysis of physiological effects of chronic psychosocial stress in mice fed 
standard (STD) or high fat diet (HFD). Table summarizes results published in Sanghez et al [19]. BW 
(Body weight), FI (Food Intake), GTT (Glucose Tolerance Test).  
 
Supplementary Table 2: Complete list of gene panel measured by quantitative real time PCR. 
 
Supplementary Figure 1: Effect of HFD feeding on Insulin pathway analysis in CON mice: 
Representation of the Insulin pathway in liver (top left) and skeletal muscle (bottom left) of CON mice 
fed HFD compare to STD. CON HFD showed an upregulation in glycolysis pathway in liver and nodes 
involved in protein synthesis, proliferation and differentiation in skeletal muscle. Adipokines (top right) 
and Insulin (bottom right) pathways in pWAT. High fat diet induced an upregulation  of the 
glucose uptake and growth and reproduction subpathways in the adipokines pathway (upper panel) 
and a downregulation of anti-lipolysis subpathway in the insulin pathway (lower panel). In this and 
following figures, subpathways significantly upregulated in the condition of interest (CON-HFD) 
compare to STD are represented with all the nodes belonging to it in red. Subpathways significantly 
downregulated are represented with all the nodes in blue. Further details on the representation of 
the pathway analysis appear in the Figures S3-S5.  
 
Supplementary Figure 2: Effect of HFD feeding on Adipokines and Insulin pathway analysis in 
SUB and DOM mice: A) Representation of the adipokines pathway in pWAT. SUB and DOM mice 
exhibited an effect of upregulation in glucose uptake pathway compare to their counterpart fed STD. B) 
Representation of Insulin pathway in skeletal muscle. SUB mice showed an upregulation in all the 
subpathways correlated to Insulin pathway resulting in an increase in glycolysis, lipolysis and anti-
lipolysis and gluconeogenesis. DOM did not showed any change in Insulin pathway in skeletal muscle. 
Further details on the representation of the pathway analysis appear in the Figures S2-S3. 
 
Supplementary Figure 3: Representative Adipokines pathway. For more detailed pathway refer to 
http://www.genome.jp/kegg-bin/show_pathway?mmu04920  
 
Supplementary Figure 4: Representative Insulin pathway. For more detailed pathway refer to 
http://www.genome.jp/kegg-bin/show_pathway?mmu04910 
 
Supplementary Figure 5: Representative PPARs pathway. For more detailed pathway refer to 
http://www.genome.jp/kegg-bin/show_pathway?mmu03320 
 
 

Supplementary STD HFD
Table2 CON SUB DOM CON SUB DOM
average SE average SE average SE average SE average SE average SE
Liver
ADRP 1.51 0.14 1.22 0.14 1.16 0.10 1.28 0.12 0.89 0.07 0.90 0.11
AP2 1.31 0.10 1.31 0.10 1.49 0.11 1.32 0.10 1.10 0.04 1.17 0.11
CD36 0.99 0.08 1.16 0.07 1.17 0.11 1.29 0.05 1.05 0.07 0.89 0.08
CPT1a 1.61 0.07 1.31 0.07 1.30 0.07 1.04 0.05 0.85 0.05 1.00 0.11
FAS 1.21 0.08 1.09 0.09 1.43 0.12 0.93 0.05 0.87 0.05 0.89 0.07
GK 0.45 0.06 0.47 0.05 0.48 0.08 1.45 0.20 1.38 0.17 0.47 0.11
GLUT2 0.55 0.03 0.74 0.04 0.81 0.07 0.96 0.05 0.85 0.04 0.76 0.09
Ins Rec 1.12 0.05 1.30 0.05 1.06 0.08 1.07 0.04 1.10 0.05 1.00 0.12
IRS1 1.34 0.09 1.09 0.07 1.28 0.08 1.07 0.06 1.12 0.06 1.02 0.12
IRS2 1.54 0.11 0.90 0.08 1.67 0.17 0.95 0.08 0.82 0.05 1.13 0.24
MCAD 1.12 0.06 1.14 0.05 1.14 0.06 1.13 0.06 0.94 0.03 0.99 0.05
PC 1.23 0.06 1.18 0.06 1.28 0.05 1.09 0.06 1.05 0.04 0.94 0.09
PEPCK 0.97 0.05 0.90 0.05 1.28 0.09 0.86 0.07 0.67 0.07 0.95 0.13
PPARa 1.18 0.07 1.08 0.05 1.26 0.06 1.17 0.07 1.08 0.05 0.93 0.09
PPARd 1.24 0.08 1.17 0.06 1.35 0.10 1.04 0.06 1.10 0.06 1.08 0.10
PPARG1 0.66 0.05 0.89 0.10 0.80 0.12 0.93 0.08 0.98 0.07 0.95 0.13
SCD1 2.18 0.28 2.28 0.28 1.92 0.24 0.23 0.05 0.25 0.05 0.09 0.02
Perigonadal WAT
ACOX1 1.75 0.30 1.59 0.16 1.91 0.13 0.84 0.07 0.83 0.07 1.21 0.16
ADIPONECTIN 1.17 0.06 1.52 0.05 1.18 0.06 1.27 0.07 1.12 0.07 1.17 0.06
AP2 3.49 0.16 4.04 0.15 3.08 0.22 4.11 0.22 4.04 0.28 4.11 0.15
DIO2 0.70 0.10 0.59 0.10 0.58 0.09 1.64 0.24 1.06 0.15 0.98 0.18
GLUT4 1.05 0.05 1.04 0.08 1.10 0.09 1.04 0.08 1.12 0.07 0.91 0.09
HSL 1.34 0.07 2.19 0.44 1.56 0.14 1.12 0.08 0.93 0.09 1.12 0.07
Ins Rec 1.14 0.12 1.10 0.07 1.26 0.21 0.82 0.06 0.73 0.05 0.62 0.04
LEPTIN 0.77 0.10 0.98 0.11 0.54 0.09 1.67 0.20 1.72 0.16 1.40 0.24
LPL 1.53 0.09 2.23 0.12 1.65 0.18 1.42 0.16 1.17 0.09 1.18 0.04
PGC1b 1.20 0.09 1.60 0.14 1.57 0.14 0.77 0.11 0.93 0.07 0.71 0.06
PPARg1 1.26 0.07 1.60 0.10 1.61 0.16 1.08 0.08 0.85 0.03 1.01 0.05
PPARg2 1.13 0.08 1.47 0.16 1.04 0.09 1.11 0.11 1.04 0.09 1.06 0.16
Sckeletal Muscle
CD36 1.03 0.06 0.99 0.04 1.12 0.05 0.96 0.06 0.99 0.08 1.18 0.16
FATP1 1.15 0.08 1.15 0.07 1.08 0.07 0.94 0.06 0.92 0.07 0.85 0.17
GK 0.83 0.14 0.74 0.13 1.02 0.21 0.99 0.09 0.75 0.08 0.53 0.09
GLUT4 2.21 0.12 1.97 0.10 2.26 0.13 2.09 0.12 1.72 0.09 1.88 0.17
Ins Rec 0.96 0.05 1.02 0.05 1.10 0.05 1.12 0.04 1.10 0.05 1.29 0.09
IRS2 1.38 0.12 0.96 0.08 1.58 0.16 1.00 0.06 0.79 0.03 0.96 0.19
JNK 1.10 0.05 0.94 0.04 1.02 0.05 0.92 0.05 0.89 0.06 0.98 0.06
MCAD 0.80 0.05 0.73 0.03 0.74 0.04 0.93 0.05 0.95 0.07 1.08 0.14
PC 1.38 0.03 1.49 0.12 1.63 0.14 1.04 0.06 0.87 0.05 1.19 0.23
PPARa 0.68 0.05 0.80 0.07 0.80 0.08 0.79 0.09 0.93 0.13 1.30 0.46
PPARg1 0.97 0.13 1.53 0.26 1.79 0.38 0.72 0.09 0.53 0.04 1.20 0.47
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